Krystal Biotech Inc | Trend line / H&SNASDAQ:KRYS (Krystal Biotech Inc)
Engages in developing and commercializing pharmaceutical products.
It offers the product, VYJUVEK.
Krystal Biotech, Inc.
No trades
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
5.87 EUR
86.13 M EUR
280.63 M EUR
24.93 M
About Krystal Biotech, Inc.
Sector
Industry
CEO
Krish S. Krishnan
Website
Headquarters
Pittsburgh
Founded
2016
Identifiers
3
ISINUS5011471027
Krystal Biotech, Inc. operates as a biotechnology company, which engages in developing and commercializing pharmaceutical products. It offers the product, VYJUVEK. The company was founded by Krish S. Krishnan and Suma M. Krishnan on April 15, 2016 and is headquartered in Pittsburgh, PA.
Related stocks
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of 4KB is 209.80 EUR — it has decreased by −4.38% in the past 24 hours. Watch Krystal Biotech, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on GETTEX exchange Krystal Biotech, Inc. stocks are traded under the ticker 4KB.
4KB stock has fallen by −1.71% compared to the previous week, the month change is a 12.72% rise, over the last year Krystal Biotech, Inc. has showed a 39.45% increase.
We've gathered analysts' opinions on Krystal Biotech, Inc. future price: according to them, 4KB price has a max estimate of 236.69 EUR and a min estimate of 168.58 EUR. Watch 4KB chart and read a more detailed Krystal Biotech, Inc. stock forecast: see what analysts think of Krystal Biotech, Inc. and suggest that you do with its stocks.
4KB stock is 4.58% volatile and has beta coefficient of 0.15. Track Krystal Biotech, Inc. stock price on the chart and check out the list of the most volatile stocks — is Krystal Biotech, Inc. there?
Today Krystal Biotech, Inc. has the market capitalization of 6.09 B, it has decreased by −4.47% over the last week.
Yes, you can track Krystal Biotech, Inc. financials in yearly and quarterly reports right on TradingView.
Krystal Biotech, Inc. is going to release the next earnings report on Mar 2, 2026. Keep track of upcoming events with our Earnings Calendar.
4KB earnings for the last quarter are 2.27 EUR per share, whereas the estimation was 0.93 EUR resulting in a 144.13% surprise. The estimated earnings for the next quarter are 1.33 EUR per share. See more details about Krystal Biotech, Inc. earnings.
Krystal Biotech, Inc. revenue for the last quarter amounts to 83.34 M EUR, despite the estimated figure of 79.41 M EUR. In the next quarter, revenue is expected to reach 89.86 M EUR.
4KB net income for the last quarter is 67.63 M EUR, while the quarter before that showed 32.54 M EUR of net income which accounts for 107.84% change. Track more Krystal Biotech, Inc. financial stats to get the full picture.
No, 4KB doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Jan 3, 2026, the company has 275 employees. See our rating of the largest employees — is Krystal Biotech, Inc. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Krystal Biotech, Inc. EBITDA is 140.28 M EUR, and current EBITDA margin is 37.84%. See more stats in Krystal Biotech, Inc. financial statements.
Like other stocks, 4KB shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Krystal Biotech, Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Krystal Biotech, Inc. technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Krystal Biotech, Inc. stock shows the buy signal. See more of Krystal Biotech, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.